P rolonged electric activation delay between 2 sites in the heart is due to slow conduction, lengthening of conduction pathways, or both. In the presence of unidirectional block and triggers, enhanced delay promotes reentrant circuits as substrate of arrhythmogenesis in various supraventricular and ventricular arrhythmias. This mechanism is well-known in the chronic stage of myocardial infarction and other types of structural heart disease, including arrhythmogenic cardiomyopathy (AC). [1] [2] [3] 
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AC can be defined as, ultimately, a structural heart disease, with signs of heart failure preceded in the early stages by electrophysiological alteration that result in electrocardiographic abnormalities and ventricular arrhythmias. AC includes primarily right ventricular, primarily left ventricular, or biventricular abnormalities. 4, 5 Arrhythmogenic right ventricular dysplasia/cardiomyopathy is well-known nomenclature for the right-sided variant. However, although histopathological and functional predominance of right ventricular abnormalities are frequently found, the left ventricle is affected in most patients as well. Moreover, at the molecular level, both ventricles are affected by altered expression and distribution of intercalated disk proteins. [6] [7] [8] Because of these considerations, AC has recently become the favored terminology of this group of frequently difficult-to-distinguish disorders.
AC is considered a genetic disorder primarily associated with gene mutations encoding desmosomal proteins, although nondesmosomal genes are also involved in a minority, but substantial number of cases. [9] [10] [11] Accumulating evidence suggests that gene mutation-related changes or distribution of desmosomal proteins give rise to altered expression and distribution of other intercalated disk proteins, including gap junction and ion channel proteins, resulting in mechanical and electric uncoupling and slow conduction and conduction block. These factors already favor reentry in the early concealed stage of the disease. It is very likely that fibrofatty alteration responsible for altered tissue architecture follows in the later overt stage of the disease. This sequence of changes is strongly supported by identification of altered distribution of the desmosomal protein plakoglobin in histologically still-unaffected left ventricular and septal tissue in patients with proven AC. 6 In addition, already in the early concealed stage of AC, ventricular fibrillation and sudden death may occur in the absence of identifiable fibrofatty changes. 10 In contrast, in the overt stage, the modified tissue architecture characterized by interconnecting vital myocardial bundles embedded in fibrotic tissue contributes importantly to further aggravation of activation delay by lengthening of conduction pathways and load mismatch at pivotal points. 1, [12] [13] [14] This highly arrhythmogenic substrate frequently is the cause of monomorphic ventricular tachycardia with left bundle branch block morphology.
During normal sinus rhythm, the right ventricular outflow tract (RVOT) is activated late during the ventricular depolarization process. This facilitates detection of prolonged activation delay with noninvasive techniques (ie, electrocardiography using the right precordial leads V 1 to V 3 and signalaveraged ECG [SAECG]).
In this issue of Circulation: Arrhythmia and Electrophysiology, Santangeli et al 15 report on the correlation between SAECG and histological evaluation of the myocardial substrate of arrhythmias originating from the RVOT. SAECG was used to detect late potentials due to local prolonged activation delay. Late potential recording was fulfilled with at least 2 of the following criteria: (1) filtered QRS duration >114 ms; (2) terminal low-amplitude (<40 μV) signal of the QRS complex >38 ms; and (3) root mean square voltage in the terminal 40 ms of the QRS complex <20 µV. Tissue sampling for histological and immunohistochemical analysis was obtained by endomyocardial biopsy. The biopsy sites were guided by electroanatomic mapping indicating abnormal myocardium with bipolar signal amplitude <1.5 mV and scar with amplitude <0.5 mV. The study was carried out in a limited number of 24 patients, 11 with late potentials and 13 without. All patients with late potential recordings showed histological abnormalities, with 7 patients compatible with AC and 4 with myocarditis. However, in the absence of late potentials, only 5 of 13 patients had normal histological findings. In the other 8 patients, 4 showed histological signs of AC, and 4 showed myocarditis. Although the numbers are low, the specificity of late potential recordings is high. Thus, patients with SAECG-positive findings should undergo extensive cardiological evaluation and molecular-genetic screening because structural heart disease is very likely. However, the sensitivity of late potential recording with the SAECG technique is very low.
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The technique is not appropriate for identifying patients without structural disease (ie, those with idiopathic ventricular tachycardia or idiopathic premature ventricular complexes). These arrhythmias from the RVOT usually are not due to reentry, and prolonged activation delay is not involved in arrhythmogenicity. Further studies are needed to evaluate whether modification of SAECG cutoff values would enhance sensitivity, as also suggested by the authors. 15 Activation delay in the RVOT can also be studied by routine 12-lead ECG recording, especially that derived from leads V 1 to V 3 . Cox et al 16 compared activation delay in 42 patients with proven AC and 27 controls with idiopathic ventricular tachycardia while off antiarrhythmic drugs. Controls had a normal ECG recording during sinus rhythm and underwent 2D transthoracic echocardiography and, in equivocal cases, MRI, left and right ventricular cine angiography, or both to exclude structural abnormalities. AC was diagnosed according to task force criteria from 1994. Activation delay parameters studied were ε waves, QRS duration >110 ms in V 1 to V 3 , QRS V 1 +V 2 +V 3 /V 4 +V 5 +V 6 >1.2, prolonged S-wave upstroke, and prolonged terminal activation duration (TAD). ECG analysis was carried out twice by 2 physicians independently in a randomized sequence and after blinding for all other results. Prolonged TAD (≥55 ms) showed the highest sensitivity. This parameter was identified in 30 of 42 (71%) patients with proven AC and in only 1 of 27 (4%) of patients with idiopathic ventricular tachycardia (P<0.001). Measurements were highly reproducible. The single patient with prolonged TAD and idiopathic ventricular tachycardia was presumably not correctly labeled as such because in addition to the ventricular tachycardia from the RVOT, a ventricular tachycardia with superior axis was recorded. Further, catheter ablation in this patient was presumably not successful because the patient remained on antiarrhythmic drug treatment. Because of the superior sensitivity and high specificity of prolonged TAD, this criterion was included in the recently revised task force criteria. 17 However, it cannot be excluded with certainty that none of the patients labeled as having idiopathic disease had AC in an early, still concealed stage.
In a more recent study, Cox et al 10 showed recording of prolonged TAD in 5 of 7 young (aged <20 years), still asymptomatic pathogenic desmosomal mutation carriers who are relatives of symptomatic index patients with proven AC. Of these 5 individuals, 4 had prolonged TAD as the only clinical abnormality. This finding is in line with the observation that ventricular fibrillation and sudden cardiac death may occur in the early concealed stage of AC. Further studies are needed to evaluate prolonged TAD as a marker for risk stratification. Because SAECG also detects activation delay, a similar perspective seems reasonable after improvement of the methodology.
We have to realize that with both electrocardiography and SAECG, detection of prolonged activation delay in the RVOT is relatively easy. However, prolonged activation delay detection in other right ventricular areas and in the left ventricle is hampered by the fact that this delay frequently is hidden within the QRS complex. Solution of this problem is important because prolonged activation delay is a precursor of arrhythmogenicity due to reentrant mechanisms and is promising for AC diagnosis in the early concealed stage and for risk stratification. Early diagnosis is crucial because sudden death may be the first manifestation of AC. 18
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